As of 2026-01-02, the Relative Valuation of CureVac NV (CVAC) is 5.34 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.52 USD, the upside of CureVac NV based on Relative Valuation is 18.2%.
The range of the Relative Valuation is 1.67 - 9.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 14.5x | 13.3x |
| Forward P/E multiples | 15.1x - 25.9x | 15.7x |
| Fair Price | 1.67 - 9.77 | 5.34 |
| Upside | -63.2% - 116.1% | 18.2% |
| Date | P/E |
| 2025-12-31 | 6.71 |
| 2025-12-30 | 6.65 |
| 2025-12-29 | 6.41 |
| 2025-12-26 | 6.38 |
| 2025-12-24 | 6.40 |
| 2025-12-23 | 6.25 |
| 2025-12-22 | 6.12 |
| 2025-12-19 | 6.18 |
| 2025-12-18 | 6.36 |
| 2025-12-17 | 6.13 |
| 2025-12-16 | 7.16 |
| 2025-12-15 | 7.42 |
| 2025-12-12 | 7.50 |
| 2025-12-11 | 7.60 |
| 2025-12-10 | 7.59 |
| 2025-12-09 | 7.60 |
| 2025-12-08 | 7.74 |
| 2025-12-05 | 7.60 |
| 2025-12-04 | 7.60 |
| 2025-12-03 | 7.66 |
| 2025-12-02 | 7.59 |
| 2025-12-01 | 7.72 |
| 2025-11-28 | 8.15 |
| 2025-11-26 | 8.14 |
| 2025-11-25 | 7.84 |
| 2025-11-24 | 7.59 |
| 2025-11-21 | 7.47 |
| 2025-11-20 | 7.60 |
| 2025-11-19 | 7.75 |
| 2025-11-18 | 7.77 |
| 2025-11-17 | 7.84 |
| 2025-11-14 | 7.84 |
| 2025-11-13 | 7.87 |
| 2025-11-12 | 7.93 |
| 2025-11-11 | 7.84 |
| 2025-11-10 | 7.77 |
| 2025-11-07 | 7.74 |
| 2025-11-06 | 7.80 |
| 2025-11-05 | 7.83 |
| 2025-11-04 | 7.87 |
| 2025-11-03 | 7.93 |
| 2025-10-31 | 7.93 |
| 2025-10-30 | 7.96 |
| 2025-10-29 | 7.99 |
| 2025-10-28 | 7.97 |
| 2025-10-27 | 7.99 |
| 2025-10-24 | 7.96 |
| 2025-10-23 | 7.99 |
| 2025-10-22 | 8.00 |
| 2025-10-21 | 7.97 |